Immunosenescence and inflammaging in the aging process: age-related diseases or longevity?

A Santoro, E Bientinesi, D Monti - Ageing research reviews, 2021 - Elsevier
During aging the immune system (IS) undergoes remarkable changes that collectively are
known as immunosenescence. It is a multifactorial and dynamic phenomenon that affects …

Dysregulated inflammation during obesity: driving disease severity in influenza virus and SARS-CoV-2 infections

KD Hulme, EC Noye, KR Short, LI Labzin - Frontiers in immunology, 2021 - frontiersin.org
Acute inflammation is a critical host defense response during viral infection. When
dysregulated, inflammation drives immunopathology and tissue damage. Excessive …

The majority of SARS-CoV-2-specific antibodies in COVID-19 patients with obesity are autoimmune and not neutralizing

D Frasca, L Reidy, M Romero, A Diaz, C Cray… - International Journal of …, 2022 - nature.com
Background/objectives Obesity decreases the secretion of SARS-CoV-2-specific IgG
antibodies in the blood of COVID-19 patients. How obesity impacts the quality of the …

Anti-CD20 therapies decrease humoral immune response to SARS-CoV-2 in patients with multiple sclerosis or neuromyelitis optica spectrum disorders

C Louapre, M Ibrahim, E Maillart, B Abdi… - Journal of Neurology …, 2022 - jnnp.bmj.com
Background SARS-CoV-2 seroconversion rate after COVID-19 may be influenced by
disease-modifying therapies (DMTs) in patients with multiple sclerosis (MS) or neuromyelitis …

Induction of SARS-CoV-2 neutralizing antibodies by CoronaVac and BNT162b2 vaccines in naïve and previously infected individuals

NA Muena, T García-Salum, C Pardo-Roa… - …, 2022 - thelancet.com
Background A major challenge of the SARS-CoV-2 pandemic is to better define" protective
thresholds" to guide the global response. We aimed to characterize the longitudinal …

B cell contribution to immunometabolic dysfunction and impaired immune responses in obesity

K Oleinika, B Slisere, D Catalán… - Clinical and …, 2022 - academic.oup.com
Obesity increases the risk of type 2 diabetes mellitus, cardiovascular disease, fatty liver
disease, and cancer. It is also linked with more severe complications from infections …

COVID-19 and obesity: fighting two pandemics with intermittent fasting

KN Ealey, J Phillips, HK Sung - Trends in Endocrinology & Metabolism, 2021 - cell.com
Obesity is strongly and independently associated with an increased risk of severe illness
and death from coronavirus disease 2019 (COVID-19). The pathophysiological changes that …

Kinetics of anti-nucleocapsid IgG response in COVID-19 immunocompetent convalescent patients

M Movsisyan, A Chopikyan, I Kasparova… - Scientific Reports, 2022 - nature.com
The comprehension of a long-term humoral immune response against SARS-CoV-2 can
shed light on the treatment and vaccination strategies of COVID-19 disease, improving the …

COVID‐19, obesity, and immune response 2 years after the pandemic: A timeline of scientific advances

M Belchior‐Bezerra, RS Lima, NI Medeiros… - Obesity …, 2022 - Wiley Online Library
In the 2 years since the COVID‐19 pandemic was officially declared, science has made
considerable strides in understanding the disease's pathophysiology, pharmacological …

Obesity dysregulates the immune response to influenza infection and vaccination through metabolic and inflammatory mechanisms

SR Shaikh, NJ MacIver, MA Beck - Annual review of nutrition, 2022 - annualreviews.org
The COVID-19 pandemic demonstrates that obesity alone, independent of comorbidities, is
a significant risk factor for severe outcomes from infection. This susceptibility mirrors a …